Concepedia

Stéphanie Klein

SK

Statistics

Publications

21

Citations

1.2K

H-Index

16

Active since

2003

Affiliations

Ionis Pharmaceuticals (United States)(Current)

AstraZeneca (United Kingdom)

University of Veterinary Medicine Hannover, Foundation

Institut de Pharmacologie Moléculaire et Cellulaire

AstraZeneca (United States)

Stéphanie Klein is an author at Ionis Pharmaceuticals (United States) specializing in life sciences, molecular biology, and medicine.

ORCID

Publications per year

2003–2025

21

Publications

21

Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment

Daniel M. Ramos, Constantin d’Ydewalle, Vijayalakshmi Gabbeta et al. · Journal of Clinical Investigation · 2019 · 193 citations · Full text

, , +17

Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS

Sarah J. Ross, Alexey S. Revenko, Lyndsey Hanson et al. · Science Translational Medicine · 2017 · 182 citations

, , +16

The Small G-protein Arf6GTP Recruits the AP-2 Adaptor Complex to Membranes

Olivia Paléotti, Eric Macia, Frédéric Luton et al. · Journal of Biological Chemistry · 2005 · 111 citations · Full text

, , +17

Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project

William S. Redfern, Karen Tse, Claire Grant et al. · PLoS ONE · 2017 · 90 citations · Full text

, , +10

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer

Alexey S. Revenko, Larissa S. Carnevalli, Charles Sinclair et al. · Journal for ImmunoTherapy of Cancer · 2022 · 86 citations · Full text

, , +16

1–5 of 21